The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
NCT00656331 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2023-07-11
Summary
The purpose of this study is to compare the effects of the cholesterol medication taken with each blood pressure medication alone on heart disease risk factors including blood pressure, cholesterol, inflammation, blood sugar control, blood vessal function, and other heart disease risk factors.
Conditions
Interventions
- DRUG
-
Amlodipine and Hydrocholorothiazide
Arm 1 gets Amlodipine and Arm 2 gets Hydrocholorothiazide
Sponsors & Collaborators
-
University of New Mexico
lead OTHER
Principal Investigators
-
Kathleen Colleran, MD · University of New Mexico
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- United States
Study Locations
More Related Trials
-
Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
NCT01842230 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion
NCT01126684 ·Status: COMPLETED ·Phase: NA
-
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
NCT00722956 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
NCT01842256 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study Between Colchicine and Atorvastatin
NCT00960323 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
NCT02579356 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
NCT06699355 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
NCT02659397 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
NCT00174330 ·Status: COMPLETED ·Phase: PHASE4
-
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
NCT00650689 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)
NCT00418834 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)
NCT00687271 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
NCT04591808 ·Status: TERMINATED ·Phase: PHASE3
-
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)
NCT00653796 ·Status: COMPLETED ·Phase: PHASE4
-
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
NCT00361283 ·Status: COMPLETED ·Phase: PHASE4
-
Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.
NCT00404599 ·Status: UNKNOWN ·Phase: PHASE4
-
Drug Interaction Study of ASC42 With Atorvastatin
NCT05464628 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
NCT01370603 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects
NCT01806324 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
NCT00276458 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy Participants
NCT01689623 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
NCT03611010 ·Status: COMPLETED ·Phase: PHASE2
-
Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)
NCT00782184 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
NCT00535405 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
NCT01370590 ·Status: COMPLETED ·Phase: PHASE3